Systemic Sclerosis Interstitial Lung Disease: A Multidisciplinary Approach to Diagnosis, Treatment and Longitudinal Management

Released On
April 24, 2020

Expires On
November 17, 2020

Media Type

Completion Time
60 minutes

Internal Medicine, Primary Care, Pulmonology, Rheumatology, Physicians, Nurse Practitioners

Scroll to the Bottom of this Information to Begin this Course

This collaborative program was developed and presented by National Jewish Health with the Mount Sinai – National Jewish Health Respiratory Institute and the Jane and Leonard Korman Respiratory Institute - Jefferson Health and National Jewish Health. Together, these three organizations collaborate on research, clinical trials and other programs extending the impact they bring to patients and furthering the understanding of respiratory illness. The Respiratory Institute model of collaboration currently brings these three entities together, collectively referred to as “The Respiratory Institutes”.

The Respiratory Institutes provide specialized programs committed to multidisciplinary consultation, advanced diagnostics, and coordinated, collaborative care for the full range of lung conditions. With expert faculty working in sync, the Institutes are well-positioned to provide education to health care providers on best practices in respiratory medicine and improving overall care coordination.


Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.


Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for pulmonologists, rheumatologists and any others who treat patients with SSc-ILD.

Program Overview

This program will highlight strategies for the diagnosis, treatment, and longitudinal management of SSc-ILD using a multidisciplinary approach.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Identify clinical features and risk factors of SSc-ILD based upon best practices for diagnosis.
  • Apply practice guidelines and clinical evidence related to current and emerging therapies to select treatments for patients with SSc-ILD.
  • Evaluate strategies for longitudinal management of SSc-ILD using a multidisciplinary approach.


Mehrnaz Maleki Fischbach, MD

Mehrnaz Maleki Fischbach

Associate Professor of Medicine
Division of Rheumatology
Director of the Rheumatology Clinic
National Jewish Health
Denver, CO

Mehrnaz Maleki Fischbach, MD, is an Associate Professor, Department of Medicine, Division of Rheumatology, at National Jewish Health. Dr. Maleki Fischbach received her medical degree at Isfahan University of Medical Sciences. She completed her internal medicine residency at Michigan State University-McLaren Regional Medical Center where she was also a Research Fellow at the Chronic Pain and Fatigue Research Center. Dr. Maleki Fischbach completed her Rheumatology Fellowship at the University of North Carolina at Chapel Hill.

Dr. Maleki Fischbach is a Clinical Instructor at University of Colorado Denver and is a member of the American College of Rheumatology, the American College of Physicians and the Rocky Mountain Rheumatism Society. She has been published in Arthritis Research & Therapy (30 July 2010), New developments in osteoarthritis. Sex differences in magnetic resonance imaging-based biomarkers and in those of joint metabolism.

Dr. Maleki Fischbach is Program Chair for the Improving the Outcomes of Patients with Osteoporosis, the CME, CNE and dietitian CPE educational activity at National Jewish Health on December 8, 2015. She has also received two internal research awards from National Jewish Health.

Maria Padilla, MD

Maria Padilla, MD

Director, Advanced Lung Disease/Interstitial Lung Disease Program
Professor of Medicine
Pulmonary, Critical Care and Sleep Medicine
Mount Sinai-National Jewish Health Respiratory Institute
New York City, NY

Maria Luisa Padilla, MD, is Professor of Medicine and Director of the Advanced Lung Disease/ILD Program at the Icahn School of Medicine at Mount Sinai in New York, New York. She received her undergraduate degree at the City College of New York and received her medical degree at the Mount Sinai School of Medicine in New York City. After completing her training as an intern and resident in Internal Medicine at Mount Sinai Hospital, Dr. Padilla pursued a fellowship in Pulmonary Medicine and Basic Science Research in Interstitial Lung Disease, also at Mount Sinai Hospital. She gained additional knowledge in Lung Transplantation and Cystic Fibrosis and directed the former Lung Transplant Program at Mount Sinai Hospital. She is a graduate of The Executive Leadership in Academic Medicine (ELAM). She is certified in Internal Medicine, Pulmonary and Critical Care Medicine.

Dr. Padilla has investigated and lectured extensively on multiple aspects of pulmonary and critical care medicine. In addition to her clinical research on pulmonary fibrosis in which she participated on multiple trials that led to the FDA approval of antifibrotic therapy for IPF, sarcoidosis, and pulmonary hypertension, she has a very active pulmonary practice and consultation service and continues her teaching interests and clinical investigation (ongoing clinical trials). Dr. Padilla is the recipient of several awards, including an Academic Award from National Institutes of Health (NIH), teaching awards, 2000 Physician of the Year Award, the Distinguished Service Award, and the Saul Horowitz Jr. Memorial Award, Jacobi Medallion at Mount Sinai Hospital. She has co-authored books on respiratory disorders and is the author or co-author of over 60 publications, presentations, and reports.

Jesse Roman, MD

Jesse Roman, MD

Professor of Medicine
CEO, Jane & Leonard Korman Respiratory Institute - Jefferson Health and National Jewish Health
Ludwig Kind Professor of Medicine and Pharmacology & Experimental Therapeutics
Enterprise Division Chief, Pulmonary, Allergy and Critical Care Medicine
Jefferson Health
Philadelphia, PA

Dr. Jesse Roman is Ludwig Kind Professor of Medicine and Pharmacology & Experimental Therapeutics; Enterprise Division Chief for Pulmonary, Allergy and Critical Care Medicine; and Chief Executive Officer of the Jane & Leonard Korman Respiratory Institute – Jefferson Health and National Jewish Health in Philadelphia, Pennsylvania. Dr. Roman received his M.D. from the University Of Puerto Rico School Of Medicine in 1983. After undergoing training in Internal Medicine at the San Juan VA Medical Center in Puerto Rico, he joined the Pulmonary & Critical Care Medicine Fellowship Program at Washington University School of Medicine, St. Louis, Missouri. In 1991, Dr. Roman joined the faculty at Emory University where he became Professor and Division Chief (2002), co-founder and Director for Research of the Emory Interstitial Lung Diseases Program (2003), and AVP and Founding Director of the Emory Center for Respiratory Health (2007). In 2009, Dr. Roman became Professor, Distinguished University Scholar, and Chairman of the Department of Medicine at the University of Louisville, Kentucky, where he remained until his move to Philadelphia in 2018. Dr. Roman remains active in patient care, clinical trials, and basic science research in pulmonary fibrosis and interstitial lung disorders, and has written extensively in the areas of lung tissue remodeling and inflammation, and on the role of extracellular matrices in the control of cellular functions. He is the current Editor-In-Chief of the American Journal of the Medical Sciences.

Jeffrey Swigris, DO, MS

Jeffrey Swigris, DO, MS

Director, Interstitial Lung Disease Program
Professor of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Denver, CO

Jeff Swigris, DO, MS is a Professor of Medicine and Director of the Interstitial Lung Disease (ILD) Program at National Jewish Health which is routinely recognized as one of the world’s top ILD programs. Dr. Swigris is regarded as a world expert in the assessment of symptoms and quality of life in patients with idiopathic pulmonary fibrosis.

Dr. Swigris’ clinical duties include evaluating and caring for patients with or suspected to have diffuse parenchymal lung disease. His individual research program is focused on the measurement of symptoms and quality of life in patients with ILD and on developing interventions to improve these all-important outcomes.

He attended Quincy University (Illinois) for his undergraduate work, earning degrees in Mathematics and Biology in 1992. He graduated from the Ohio University College of Osteopathic Medicine in 1996. He completed his Internal Medicine residency at the Cleveland Clinic Foundation in Cleveland, Ohio where he received the award for Senior Medical Resident of the Year in 2000. Dr. Swigris completed his Pulmonary and Critical Care Medicine fellowship at Stanford University in 2004, a year in which he also earned a Master of Science degree from Stanford in Epidemiology.

Dr. Swigris has been a member of the National Jewish Health faculty since 2005.

Accreditation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

National Jewish Health designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, CME/CE approval committee, and those in a position to control the content of this activity disclose any relevant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties. All CME/CE educational activities sponsored by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

Faculty Presenters

Mehrnaz Maleki Fischbach, MD has no financial relationships to disclose.

Maria Padilla, MD discloses that she is on an advisory board for Boehringer Ingelheim, a consultant for Genentech and Takeda as well as a speaker for Genentech and American College of Allergy and Immunology.

Jesse Roman, MD discloses that he is on a steering committee for Boehringer Ingelheim and conducts research for Galapagos, Genentech and Galecto Biotech.

Jeffrey Swigris, DO, MS discloses that he is a consultant and receives grant funding for Boehringer Ingelheim and Genenetch as well as a speaker for Genentech.

Program Planners and Reviewers

Mandy Comeau has no relevant financial relationships to disclose.

Stephanie Corder, ND, RN has no relevant financial relationships to disclose.

Lia R. Matarrese McGibbon, DO has no relevant financial relationships to disclose.

Amen Sergew, MD has no relevant financial relationships to disclose.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Submit the evaluation form.

Certificates will be emailed to the participant

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.


National Jewish Health ("NJH") and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, "NJH Parties") shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.

By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.

Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

Contact Information

For CME questions, please contact National Jewish Health at

This material was originally presented as an adjunct symposium to the American College of Chest Physicians Annual Meeting (CHEST 2019) in New Orleans, Louisiana.